CD200 and rheumatoid arthritis: Significant negative correlation between CD200R1 – CD200 receptor 1 – expression in monocytes-derived macrophages and disease activity in RA patients was shown to support potential involvement of the CD200/CD200R1 pathway in the pathogenesis of RA and implicate CD200R1 as a valuable biomarker of disease activity [34].